- Home
- DRUG vs TCX Comparison
DRUG vs TCX Comparison
Compare DRUG & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- TCX
- Stock Information
- Founded
- DRUG 2019
- TCX 1992
- Country
- DRUG United States
- TCX Canada
- Employees
- DRUG N/A
- TCX N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- TCX EDP Services
- Sector
- DRUG Health Care
- TCX Technology
- Exchange
- DRUG Nasdaq
- TCX Nasdaq
- Market Cap
- DRUG 210.7M
- TCX 179.0M
- IPO Year
- DRUG N/A
- TCX 1996
- Fundamental
- Price
- DRUG $32.38
- TCX $16.27
- Analyst Decision
- DRUG
- TCX
- Analyst Count
- DRUG 0
- TCX 0
- Target Price
- DRUG N/A
- TCX N/A
- AVG Volume (30 Days)
- DRUG 382.4K
- TCX 50.4K
- Earning Date
- DRUG 11-26-2024
- TCX 11-07-2024
- Dividend Yield
- DRUG N/A
- TCX N/A
- EPS Growth
- DRUG N/A
- TCX N/A
- EPS
- DRUG N/A
- TCX N/A
- Revenue
- DRUG N/A
- TCX $356,135,000.00
- Revenue This Year
- DRUG N/A
- TCX $8.16
- Revenue Next Year
- DRUG N/A
- TCX N/A
- P/E Ratio
- DRUG N/A
- TCX N/A
- Revenue Growth
- DRUG N/A
- TCX 7.50
- 52 Week Low
- DRUG $0.93
- TCX $15.01
- 52 Week High
- DRUG $79.02
- TCX $28.66
- Technical
- Relative Strength Index (RSI)
- DRUG 43.69
- TCX 37.25
- Support Level
- DRUG $36.02
- TCX $15.57
- Resistance Level
- DRUG $44.70
- TCX $16.24
- Average True Range (ATR)
- DRUG 5.79
- TCX 0.89
- MACD
- DRUG -3.22
- TCX -0.02
- Stochastic Oscillator
- DRUG 6.26
- TCX 31.74
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.